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Signalling in viral entry
Abstract
Viral infections are serious battles between pathogens and hosts. They can result in cell death,
elimination of the virus or latent infection keeping both cells and pathogens alive. The outcome of an
infection is often determined by cell signalling. Viruses deliver genomes and proteins with signalling
potential into target cells and thereby alter the metabolism of the host. Virus interactions with cell
surface receptors can elicit two types of signals, conformational changes of viral particles, and
intracellular signals triggering specific cellular reactions. Responses by cells include stimulation of
innate and adaptive immunity, growth, proliferation, survival and apoptosis. In addition, virus-activated
cell signalling boosts viral entry and gene delivery, as recently shon for adenoviruses and
adeno-associated viruses. This review illustrates that multiple activation of host cells during viral entry
profoundly impacts the elaborate relationship between hosts and viral pathogens.
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2ABSTRACT
Viral infections are serious battles between pathogens and hosts.  They can result in cell
death, elimination of the virus, or latent infection keeping both cells and pathogens alive.
The outcome of an infection is often determined by cell signaling.  Viruses deliver
genomes and proteins with signalling potential into target cells and thereby alter the
metabolism of the host.  Virus interactions with cell surface receptors can elicit two types
of signals, extracellular signals which induce conformational changes of viral particles,
and intracellular signals which trigger specific cellular reactions.  Responses by cells
include stimulation of innate and adaptive immunity, growth, proliferation and survival.  In
addition, virus-activated cell signalling boosts viral entry and gene delivery, as recently
shown for adenoviruses and adeno-associated viruses.  This review illustrates that
multiple activation of host cells during viral entry profoundly impacts the elaborate
relationship between hosts and viral pathogens.
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31. Viral interactions with cells
Viruses are tiny and are largely dependent on their hosts for survival.  They propagate by
replicating inside their host’s cells.  Viruses carry a minimal amount of information with
them.  A thin protein coat wraps around a small bag of genes.  Unlike cellular genomes,
which are protected and regulated by a variety of different polypeptides, viral genomes
encode only a few coat and regulatory proteins [1]. Viruses use their proteins repetitively
to build up regular geometrical ‘capsids’ [2], demonstrating that they have evolved
effective use of their genetic and structural outfit [3].
Despite their apparent simplicity, viruses attract serious concern for the misery and
illness they cause [4].  Most people regard viruses as uninvited and opportunistic guests
which struggle with their host in an effort to replicate and spread their genetic material.
Virally transmitted diseases range from the common cold to numerous forms of
immunodeficiencies and cancer.  Large scale vaccination programmes have led to the
prevention of some virus-caused diseases, such as poliomyelitis, hepatitis B, virus-
associated chronic liver disease, and cancer of the liver [5].  On the other hand, the
simplicity of viruses has made them useful instruments for the study of genetics, cell and
structural biology, immunology and biochemistry [6].  Studies of viruses have also made
major contributions to our understanding of principle cell functions, including the structure
of DNA, genomic regulation, transcription, processing and transport of RNA, protein
trafficking, and evolution [3; 7]. Viral research has even contradicted a long standing
dogma of molecular biology, through the discovery that RNA-containing retroviruses
reverse the normal flow of genetic information by using an enzyme, reverse
transcriptase, to transcribe single stranded RNA into double stranded DNA [8; 9].  In
contrast to the standard view, viruses might even provide essential functions for the
host..  One hypothesis proposes that endogenous retroviruses (ERVs) of mammals
locally suppress a cellular immune response against the growing placental tissue, thus
4supporting acceptance of the allogeneic embryo in the mother [10].  A recent report goes
further to suggest that a cellular gene captured by a human ERV serves an important
function in the generation of the trophoblast tissue by stimulating cell-cell fusion [11].
Another attractive speculation is that virus-like transposons are at the evolutionary origin
of immunoglobulin heavy chain and the T-cell receptor b-chain assembly in immature B
and T cells, respectively [12].
But how does it happen that viruses utilise their targets so effectively, given that host
benefits from viral infections seem to be scarce?  The short answer to this question is
that viruses are extremely well-adapted to their hosts.  A major part of this adaptation is
that viruses manipulate host cell signalling.  Biochemical and genomic analyses in the
last decades have revealed that viruses harbor both genetic and nongenetic information
with signalling potential [3; 13]. At least three principal mechanisms account for viral
activation of cells (Fig. 1).  The delivery of signalling genes is probably the best studied
mechanism, while deposition of signalling proteins by incoming viral particles and
activation of surface receptors are receiving increasing attention.  This review aims to
illustrate how viruses utilise signalling.  I highlight that the process of cell entry by viruses
can depend on signalling.   A detailed review of viral structures and other aspects of viral
life cycles is available elsewhere [for review, see e.g., 14; 15-18].
2. Delivery of signalling genes and proteins
The advent of high resolution electron microscopy and reproducible cell culture
technology about 50 years ago has enabled the tracking of intracellular viruses and viral
genomes during infections.  Sequencing of viral genomes and inventory of viral proteins
have revealed that the genomes of certain retroviruses, for example, contain cellular
genes of crucial signalling function that can lead to cell transformation and oncogenesis
(Fig. 1A).  In fact, the first oncogene discovered was the cellular non-receptor tyrosine
5kinase Src, pirated by the chicken Rous sarcoma virus [19].  Many other cell-derived
oncogenes have since been identified in transforming retroviruses.  The corresponding
cell-owned proto-oncogenes are typically involved in mitogenic signalling and include
peptide growth factors, growth factor receptors, protein and lipid kinases, G-proteins and
transcription factors [reviewed in 20; 21-23].  Viral genomes also contain genes to
counteract host defence mechanisms.  They are necessary for viral survival in an
infected organism, since acute infections are invariably countered by an innate immune
response, mounting type I and type II interferons (IFNs), cytokines and increased levels
of natural killer cell activity [reviewed in 24].  For example, the multifunctional cytokine
tumor necrosis factor (TNF- a ) is produced in activated monocytes and macrophages and
activates caspases that lead to apoptosis of infected cells.  Viral countermeasures
include the downregulation of immune modulating proteins, inhibition of apoptosis,
dysregulation of cytokine production and even destruction of immune cells [for reviews,
see 25; 26].  Adenoviruses, e.g., counteract the lytic action of TNF- a  by a variety of
proteins encoded in the E3 region [27].  Poxviruses produce a number of soluble cytokine
receptors that act as decoy molecules to neutralize cytokines [28].  In addition, herpes-
and poxviruses encode seven transmembrane G-protein coupled receptors (GPCR),
presumably derived from the host chemokine system [for recent reviews, see 29; 30].
Although most of these receptors are still orphan receptors, the human herpesvirus 8
protein ORF74 seems to be positively modulated by angiogenic chemokines and is
associated with cell transformation through phospholipase C and MAPK signalling
pathways.  It is likely that ORF74 has a major role in HHV-8 associated Karposi’s
sarcomas.  This example underscores the principle that viruses take control of cell
proliferation by pirating and modulating cellular genes.  These modulations involve cell
cycle control intercellular signalling subcellular trafficking of membranes and cell
migration [31-34].
Viruses not only pirate signalling genes but also borrow proteins (and lipids) and return
them to the cell upon entry (Fig. 1B).  Although many cellular proteins can be found in
6highly purified enveloped viruses, only a few of them have been functionally
characterized.  One example is the cyclophilin A (CPA) captured by a retrovirus, the
human immunodeficiency virus (HIV) [35].  CPA is a protein that helps maintaining proper
protein conformations by catalyzing peptidyl-prolyl cis-trans isomerizations.  It is required
for infection by virtue of its binding to the viral Gag polyprotein [36].  Another example is
the mitogen-activated kinase (MAPK), a component of the Ras signalling pathway.  It is
also captured by HIV and returned into the cell to potentiate cell growth and survival [37].
The importance of regulatory viral mechanisms designed to instantly interfere with host
functions is underscored by the fact that herpes viruses deliver serveral hundred copies
of viral transcription factors into a host cell [reviewed in 38].  Intriguingly, these viruses
transfer yet another class of biomolecules into target cells.  A recent study has shown
that human cytomegalovirus (HCMV), a b -herpesvirus with an infectious DNA genome of
about 200 different genes, also delivers at least four different viral RNA transcripts into
the host cell [39].  One of these transcripts encodes a protein with a cleavable signal
sequence targeting the secretory pathway.  Although the precise functions of the viral
mRNAs remain to be determined, this strategy allows HCMV to express viral genes
immediately after entry, in the absence of transcription.  This strategy significantly
extends the viral potential to manipulate cell functions, independent of host control.
3. Receptors for viral attachment
Much work has been devoted to the identification of viral receptors.  The receptor is of
central importance for infection and typically serves to enrich virus particles on target
cells.  Viruses have selected their primary receptors on the basis of availability and
accessibility, functional coupling to co-receptors and perhaps also downregulation to
prevent superinfection and support viral release [reviewed in 40].  Members from one
virus family can choose a large variety of receptors, as exemplified in a recent survey of
7retroviral receptors [reviewed in 41].  Broad availability is a prominent feature of large
glycosamino-glycans, present in heparan sulphate and chondroitin sulphate
proteoglycans.  Glycosamino-glycans have been reported to serve as primary attachment
sites for HSV-1 [42; 43], CMV [44], adeno-associated virus-2 (AAV-2) [45] and for the
subgroup C adenoviruses Ad-2 and Ad-5 [46].  In many instances, the biological role of
viral binding to glycosamino-glycans is still unclear and it remains an open question if
heparan sulfate binding is a decisive property to determine tissue specific viral
replication.  Interestingly, unmodified heparan sulfate proteoglycans are sufficient for
HSV-1 binding but not for entry which seems to require sulfation of specific glucosamine
residues [47].  Along the same lines, sialic acid residues present on glycoproteins in an
a 2-3 glycosidic linkage appear to serve as primary receptors for the subgroup D
adenoviruses Ad-8 and Ad-37 [48; 49] and also for AAV-5 [50], and it has been reported
that Ad-37 binds a 50 kDa protein independent of sialic acid [51].  This suggests that
more than the sugar moiety is required for surface binding.  In any case, it is unknown at
present whether viral binding to heparan sulfate proteoglycans or sugar moieties of other
glycoproteins directly induces cell signaling.
Primary receptors can contain built-in signalling functions (Fig. 1C).  Examples include
the acetylcholine receptor for rabies virus [52], the low density lipoprotein receptor for
minor group human rhinoviruses [53] and a tissue necrosis factor receptor-related protein
for avian leukosis sarcoma viruses [54].  In many cases, the signals from activation of
primary viral receptors are not sufficient to stimulate viral entry, as shown, for example, in
case of the T-cell receptor CD4 of HIV [reviewed in 55; 56].  CD4 is a member of the
immunoglobulin (Ig)-gene family of receptors that widely serve as primary viral receptors.
Ig-family receptors also include the poliovirus receptor [57] and intercellular adhesion
molecule 1 for major group rhinoviruses [58], a regulator of complement activation CD46
for the Edmonston strains and vaccine strains of measles virus (MV) and also human
herpesvirus 6 infections [59].  Recently, a B and T-cell receptor of the Edmonston strain
8and clinical stains of MV has been identified, the signalling lymphocyte activation
molecule (SLAM) [60].
The coxsackie B virus adenovirus receptor (CAR) is yet another Ig-family member [see
Fig. 2, and 61; 62].  CAR is a broadly distributed type I membrane protein and serves as
the major receptor for adenoviruses of subgroups A, C, D, E and F [63].  In highly
polarized epithelial cells, the availability of CAR is restricted to the basolateral surface
and thus limits access of subgroup C virus Ad-2 or Ad-5 to the basolateral membrane of
normal bronchiolar epithelial cells [64].  Virus binding to CAR is very tight and most likely
involves an avidity mechanism which trimerizes CAR [65].  The extracellular N-terminal
Ig-like domain D1 of CAR is sufficient for binding the distal knob domain of the viral fiber
protein, as indicated by functional analyses and X-ray diffraction studies [66-68].  The
tight coupling of CAR to fiber has been exploited by generating fusion proteins of the
extracellular domains D1 and D2 of CAR and various cellular ligands that bind surface
receptors on particular cell types [69].  Using the Fc domain of a human IgG as a ligand,
this strategy has recently allowed for highly efficient retargeting of adenovirus to human
monocytic cells lacking CAR [70].  These results suggest that CAR is not required for
adenovirus infections, provided that the virus is able to recruit cell functions that facilitate
appropriate viral delivery.  Consistently, the intracellular and transmembrane domains of
CAR are dispensable for infection of nonpolarized cells with Ad-2 and Ad-5, as shown
with glycosyl-phosphatidyl-inositol (GPI) anchored, C-terminally truncated CAR [71].
Transgenic mice expressing truncated CAR in essentially all tissues allowed efficient
infections of lymphoid cells that are normally resistant to Ad infections [72].  These
results raise the notion that CAR is not directly involved in transducing signals for viral
infection.  It is, however, possible that CAR cooperates with membrane spanning
proteins, such as integrin coreceptors [73], and thus generates signals boosting infection.
Along these lines, the C-terminal cytosolic CAR domain harbors sorting signals for
targeting to the basolateral membrane where integrin coreceptors are located [74].
Interestingly, apical expression of truncated GPI-linked CAR seems to support infection
9of human airway epithelial cells with apically applied adenovirus [75].  Since polarized
airway epithelial cells are resistant to many viral and nonviral vectors added through the
airways, it will be interesting to see if truncated GPI-CAR is sufficient to achieve
adenoviral gene delivery in vivo.  Given the complexity of viral host interactions it will,
however, not be surprising to find that surface receptors with signalling potential are
needed for apical entry.
4. Coreceptors
Viruses not only bind primary receptors, they also recruit and activate coreceptors at the
cell surface, similar to bacterial pathogens and the complex gamete interactions in
metazoans.  One of the first coreceptors has been found for Ad-2 and Ad-5, namely a vb 5
integrin [see Fig. 2, and 73].  More recently, a 5 b 1 [76] and a vb 1 integrin coreceptors [77]
have been discovered.  Keratinocytes and epithelial cells from b 5 integrin knock out mice
were found to be equally well infected with Ad-5 as b 5 positive cells [78] suggesting that
redundant integrin functions may coordinate viral entry.  Coreceptors were also found for
the lentivirus HIV-1 [79], herpesviruses, including the a -herpesviruses HSV-1 and
pseudorabies virus [80-82], Epstein-Barr virus [83] and the retrovirus feline leukemia
virus [84].  For adeno-associated virus 2 (AAV-2) two different coreceptors have been
described, a vb 5 integrins [85] and basic fibroblast growth factor receptor 1 [86].  The
involvement of integrin coreceptors in AAV-2 entry has recently been challenged [87].
Coreceptors typically bind particles with a lower affinity than the primary receptors and
therefore act after viral binding to primary receptors.  They are particularly important if the
primary receptor is not coupled to virus uptake mechanisms or does not properly activate
the target cell.  In the case of HIV, the chemokine receptors CXCR4 (for T-cell tropic
viruses) and CCR5 (for macrophage tropic viruses) act in concert with primary receptors
to mediate fusion of the viral and cellular membranes by activating the viral envelope
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protein (env) gp120/gp41 [reviewed in 56; 88].  The CXCR4 and CCR5 coreceptors are
heptahelical transmembrane proteins.  They are coupled to heterotrimeric G-proteins and
transduce a complex array of signals upon chemokine ligation [for review, see 89; 90].
Besides stimulating HIV entry and completion of early replication events, the CCR5
coreceptor appears to trigger intracellular signalling events that boost both the
recruitment of susceptible monocytes and macrophages to sites of viral replication [91;
92].  Although HIV infections stimulate the production of chemokines from a variety of cell
types, chemokine signalling is not required for fusion of the viral membrane with the
plasma membrane.  Instead, chemokines can block contacts between viral glycoproteins
and the coreceptor and have a role in coreceptor downregulation [reviewed in 93].
Exactly how coreceptor-induced signalling cooperates with signals from the primary
receptor during HIV infections is a major challenge for future investigations.
5. Structural changes of viral particles upon entry
Among the first consequences of viral binding to surface receptors are changes in the
structure of many virus particles.  Capsid changes can be important for viral entry and
are often followed by limited disassembly steps, necessary for complete dismantling of
the viral particle and exposure of the genome at later stages [94].  Initial changes of viral
structures occur upon binding of the primary or secondary receptors.  In the case of non-
enveloped viruses this can provoke conformational changes in the capsid or lead to loss
of capsid components.  Capsid destabilizations at the cell surface are crucial for
infections with many picorna viruses, including polioviruses, rhinoviruses and
echoviruses [95-98], reovirus [99] and also Ad-2 [100; 101].  Accordingly, small anti-viral
chemicals and peptides are being developed that bind to critical regions of viral capsids
or, alternatively, to the viral receptor and thus prevent particle alterations and subsequent
entry [102-105].
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In the case of enveloped viruses, receptor binding can trigger a fusion reaction of the
viral membrane with the plasma membrane.  This has been shown for the avian
sarcoma/leukosis virus (ASLV) [106; 107] primate retroviruses [108], lentiviruses
including HIV [reviewed in 109] and members of the herpesvirus family, such as HSV-1
[reviewed in 110; 111].  Other viruses including influenza virus, vesicular stomatitis virus
and Semliki forest virus fuse their lipids with cellular endosomes upon exposure to low
pH [for review, see 112].  This latter strategy enables viruses to take a ride within cellular
vesicles and pass through the cortical actin barrier towards their replication site.
6. Cell activations during entry
Productive viral infections are typically associated with profound changes of the cellular
transcription machinery often enhancing the expression levels of both cellular and viral
genes [reviewed in 3].  In addition, levels of stress proteins are increased to facilitate
replication and particle formation and also enhance the recognition of infected cells by
the immune system [113-115].  One of the most immediate cell reactions to a viral
infection is, however, the immune response.
6.1. Stimulation of the innate immune system
An initial anti-viral response is mounted immediately after infection by setting off an
innate immune response to protect cells and vital organs.  Type I interferons ( a - and b -
IFN) are generated within hours upon infection by a large variety of viral agents.  The
type I INF response is crucial for restricting the exponential speed of viral spread, as
indicated by type I INF receptor knock out mice which exhibit a strongly increased
sensitivity to viral infections [116].  The second branch of the immediate immune defence
is the type II interferon (g -IFN) system mounted upon activation of immune cells
[reviewed in 117].  These activations can involve a large variety of cytokines and
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chemokines and many cell types including antigen presenting cells, g -IFN producing cells
and natural killer cells [for recent reviews, see 118; 119; 120].
The spectrum of induced cytokines and chemokines largely depends on the type of viral
infection and the types of recruited immune cells [reviewed in 121].  One important
aspect of the innate immune system is activated by pro-inflammatory cytokines from
macrophages and includes interleukin 1 (IL-1), IL-6 and TNF-a .  IL-1 signals through the
IL-1 receptor, the founding member of a diverse superfamily of receptors which share a
cytosolic domain termed Toll/IL-1 receptor (TIR) domain.  TIR couples to various adaptor
proteins, small G-proteins of the Rho family and receptor-associated kinases (IRAKs)
and activates nuclear factor-kappa B (NFkB) and other protein kinases, such as
p38/mitogen activated protein kinase (p38/MAPK).  Interestingly, incoming adenoviral
vectors elicit an early expression of a C-X-C chemokine (within 3 hours) by activating
NFkB in the absence of g -IFN and TNF-a .  They elicit a potent T-helper immune
response consisting of CD8+ restricted cytotoxic T-lymphocytes that are directed against
viral proteins [122].  Although the signalling pathways upstream of NFkB are currently
unknown, these results indicate that both immunogenic and signalling properties of the
viral capsid have an early impact on the nature of host anti-viral responses.
6.2. Triggering the p38/MAPK pathway
p38/MAPK is one of three major types of MAPKs in mammalian cells [for review, see
123].  It is triggered by diverse extracellular stimuli including UV-light, irradiation, heat
shock, osmotic stress, proinflammatory cytokines and certain mitogens.  These activate a
cascade of upstream kinases and phosphatases and have a variety of physiological
effects, including cytokine production, cytoskeletal reorganisation and apoptosis [for a
review, see 124].  p38/MAPK activation has been documented for infections with
rhinoviruses [125], herpesviruses [126-128], HIV [129], simian immunodeficiency virus
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(SIV) [130] and adenoviruses [see Fig. 3, and 131].  Instillations of adenovirus into
mouse respiratory tracts have shown, for example, that virus entered alveolar
macrophages and within 30 min induced the transcription of TNF- a  and IL-6 [132].  This
suggested that the p38/MAPK pathway is part of an anti-adenoviral defence system.
The p38/MAPK pathway is, however, also exploited by viral pathogens.  For example,
HIV utilizes p38/MAPK activations to control gene expression from its long terminal
repeat [133].  Adenovirus usurps the p38/MAPK pathway to modulate the splice site
selection on its immediate early E1A pre-messenger RNA, apparently by altering the
nucleo-cytoplasmic distribution of cellular splicing facctors [134].  This was found in a
reporter assay, where the induction of p38/MAPK by sorbitol gave rise to the long 12S
and 13S E1A transcripts and reduced the levels of the short 9S transcripts.  Both 12S
and 13S E1A transcripts are prevalent during productive adenoviral infections and induce
early viral genes and also the 70 kDa heat shock gene, albeit at different efficiencies
[135].  Targeting the p38/MAPK pathway for anti-viral therapies might thus be an
interesting option.
6.3. Activation of extracellular signal regulated kinases (ERKs)
Besides triggering the innate immune system, many viruses activate extracellular signal
regulated kinases (ERKs).  ERKs belong to the mitogen activated protein kinase (MAPK)
family, which is activated by a large variety of growth factors binding to their cell surface
receptors.  The ERK pathway is a major pathway downstream of Ras and regulates cell
growth and differentiation [for a review, see 124].  The prototypic activation serves to
regulate the activity of transcription factors including serum response factor, AP1
consisting of Fos and Jun subunits and cyclic AMP responsive element binding protein
(CREB) [for reviews, see 136; 137].  ERKs are also activated by many DNA tumor
viruses, including HCMV [138], Karposi sarcoma associated herpesvirus (KSHV) [139],
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hepatitis B and C viruses [140; 141], papilloma virus [142], simian virus 40 (SV40) [143;
144] and adenoviruses [131; 145].  For example, HCMV stimulates sustained ERK
activity, while KSHV expresses the highly polymorphic kaposin A type II transmembrane
protein preferentially during the latent phase of B-cell infections.  Kaposin A is able to
transform rat fibroblasts and directly interacts with cytohesin-1, a guanine nucleotide
exchange factor of the small GTPase Arf-1.  Activation of cytohesin then leads to ERK
activation by a yet unknown mechanism.  SV40 triggers ERK by virtue of the small tumor
antigen which binds to and inhibits the protein phosphatase 2A, a deactivator of ERKs
[reviewed in 143].  ERKs are also turned on in HIV infections by a complex series of
reactions requiring the CD4 receptor, the tyrosine kinase Lck and the MEK kinase Raf-1
but in some cases also involve the coreceptors CXCR4 and CCR5 [for reviews, see 121;
129; 146].  Together with additional signals these activations are thought to modulate the
host immune response.
Further illustrations of viral control over ERK activations have recently come from studies
of RNA viruses, including the common cold-causing influenza virus [147], the neurotropic,
non-cytolytic Borna disease virus [148] and the paramyxovirus respiratory syncytial virus
RSV [149].  Interestingly, the production of progeny influenza and Borna disease virions
was substantially diminished in cells treated with inhibitors of the ERK activating kinase
MEK.  Since cell integrity was apparently not affected by these inhibitors, the ERK
pathway may be a potential target for anti-viral therapies.
ERKs are also activated by incoming virus particles, as demonstrated with adenovirus.
Activation of p42/44 ERKs depends on the viral coreceptor a v integrin and eventually
leads to the production of IL-8 [145].  It is expected that Ras and Raf are major
contributors to early ERK activation by adenovirus, since incoming virus also activates
protein kinase A [131], an antagonist of Ras-independent activations of Raf-1 [150].  In
the case of adenovirus, ERK activation has also post entry effects.  It leads to
phosphorylation of the E1A transactivator which in turn activates the transcription of the
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viral E4 genes [151].  Whether virally activated PKA has post entry effects, for example
activation of CREB is not known, but it is known that PKA phosphorylates and activates
p65/NFkB which cooperates in Jurkat T cells with the transcriptional coactivator
p300/CBP [152].  Interestingly, NFkB binds to the E3 region of the adenoviral genome in
lymphoid cells and seems to enhance expression of E3 proteins which are required for
immune evasion and viral persistance [153].  The action of NFkB is turned off by the
early viral E1B 19K protein which ensures that the infected cell is not undergoing
premature apoptosis [154].
6.4. Viral targeting to Ras/MAPK activated cells
Besides driving the cell cycle and coordinating anti-viral responses, an activated
Ras/MAPK pathway can also have distinct proviral effects by rendering target cell more
vulnerable to lytic viral infections.  Initial studies with NIH3T3 cells showed that reovirus,
a double stranded RNA virus lytically replicated in cells with an activated Ras/MAPK
pathway [155; 156].  In non-activated cells reovirus replicated poorly, possibly due to
interferon-induced protein kinase R (PKR).  PKR phosphorylates the translation initiation
factor eIF2a  which leads to a shut down of host translation due to trapping of guanine
nucleotide exchange factors.  The activated Ras/MAPK pathway phosphorylates and
inhibits PKR and thus permits translation of viral mRNAs.  Interestingly, the unrelated
HSV-1 takes advantage of the activated Ras/MAPK pathway in a similar way as reovirus
and preferentially replicates in Ras-activated cells [157].  In addition to the cellular branch
of PKR inactivation, HSV-1 takes advantage of a viral gene product, ICP34.5 to shut
down PKR.  ICP34.5 is thought to antagonize PKR by forming a complex with protein
phosphatase 1 and triggering dephosphorylation of eIF2 a  [158].  Likewise, adenoviruses
have developed further mechanisms including virus-associated RNAs (VA RNAs) to
inactivate PKR [reviewed in 159].  It will be interesting to see if oncolytic viruses in
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general rely on both a cellular and a viral branch to inactivate PKR and drive virus
production.
6.5. Cell survival
While activation of cell growth and proliferation is crucial for many viral infections, it does
not generally ensure that the infected cell survives long enough to give raise to sufficient
amounts of progeny virus and sustain the infection.  Cell survival pathways are
conserved from Drosophila to man and phosphoinositide 3-kinases (PI3Ks) have a key
role.  They phosphorylate the 3'-OH position of the inositol ring of inositol phospholipids
and give rise to three lipid products, PtdIns(3)P, PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3).
These lipids bind to the pleckstrin homology (PH) domains [160], FYVE containing ring
domains [161] and also PX domains of proteins [reviewed in 162].  Thus, they control the
activity and subcellular localization of a diverse array of signal transduction molecules
involved in cell survival and migration, vesicular trafficking and cytoskeletal organization.
There are three classes of PI3Ks [for reviews, see 163; 164].  Class I PI3Ks are
heterodimers of a catalytic (p110) and a regulatory subunit (p50 to p85) binding via Src
homology domain 2 (SH2) to phospho-tyrosine residues of activated receptor tyrosine
kinases.  One of the PI3K isoforms does not bind phospho-tyrosines but instead couples
to b,g  subunits of heterotrimeric G-proteins.  All class I enzymes phosphorylate PtdIns,
PtdIns(4)P and PtdIns(4,5)P2 in vitro with PtdIns(4,5)P2 preference in vivo .  The class II
PI3Ks are distinguished by a PtdIns and PtdIns(4)P substrate preference and the
presence of a carboxy-terminal C2 domain that binds calcium.  The prototypic member of
class III PI3Ks is the yeast Vps34p which is mainly implicated in vesicular trafficking.
Adenovirus has been one of the first incoming viruses shown to activate PI3K [see Fig. 3,
and 165].  Anti-phospho-tyrosine immunoprecipitates from Ad-5 infected SW480 colon
carcinoma cells contained enhanced activities of PI3K compared to non-infected cells.
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The assay measured the appearance of PtdIns(3,4,5)P(3) suggestive of class I PI3Ks
activation.  Stimulation of PtdIns(3,4,5)P(3) formation was strongest during viral entry and
was blocked by either wortmannin or overexpression of the SH2 domain of the regulatory
protein p85.  Since the purified adenoviral capsid protein penton base alone enhanced
PI3K activity, it is likely that penton base ligation of a v integrins was sufficient for
activation of PI3K.  Whether virally activated integrins crosstalk with growth factor
receptors or induce signalling on their own is not known.  It is known, however, that the
integrin-associated tyrosine kinase focal adhesion kinase (FAK) is not needed for
adenovirus-triggered PI3K activation and entry [166].  The FAK-associated adaptor
p130(CAS), however, somehow binds p85 and supports receptor-mediated Ad-2 and Ad-
5 entry.  Molecular links between PI3K activation and endocytic uptake are emerging.
Recent evidence shows that class II PI3Ks are activated upon binding to clathrin at the
plasma membrane and in the trans-Golgi network [167].  This suggests that
phosphoinositide lipids are generated at sites of clathrin coat formation, and this may
coordinate the recruitment of the endocytic machinery.  The broad spectrum of regulatory
PI3K actions and the complexity of Ad entry, however, also suggest further roles of these
enzymes in viral endocytosis, membrane trafficking and/or cytoplasmic transport.
A second virus particle shown to activate PI3K is AAV-2 [Fig. 4A, and 168].  AAVs are
lipid-free single stranded DNA parvoviruses (see 7.1.2. Parvoviruses).  Similar to Ad-5,
AAV-2 mediated PI3K activation in HeLa cells was downstream of a vb 5 integrins but,
surprisingly and in contrast to Ad-5, Rac1 activation appeared to be upstream of PI3K.  In
both cases the actin cytoskeleton was required for viral uptake but PI3K activation was
not required for AAV-2 uptake.  Instead, PI3K was involved in trafficking of AAV-2
containing endocytic vesicles towards the nucleus, consistent with the earlier notion that
hVPS34 facilitated movement of Rab5-positive endosomes along microtubules [169].
More recently, incoming HCMV was found to activate PI3K in quiescent fibroblasts [170].
Like in Ad-5 and AAV-2 infected cells, PI3K activation was transient peaking at 15 to 30
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min p.i..  Interestingly, the cellular kinases Akt and p70/S6K and the transcription factor
NFkB were activated in a PI3K-dependent manner suggesting that CMV induces cell
survival pathways during entry.  In the replicative phase, there was a second burst of
PI3K activity which was maintained throughout the infection.  PI3K inhibitors had no
effect on viral uptake but inhibited replication.  This situation is reminiscent of platelet-
derived growth factor (PDGF) activated HepG2 cells which exhibited an initial peak of
PI3K activity for early stimulations and a later PI3K peak for S-phase induction [171].
7. Signals boosting viral entry
Activation of the Ras/MAPK pathway serves multiple viral and cellular objectives, but
there is little evidence that it affects viral entry.  This raises the question if uptake of viral
particles is regulated or rather occurs constitutively, under stealth conditions.  An
example of a silent strategy is provided by one form of vaccinia virus, the extracellular
enveloped virus (EEV), but entry of the intracellular mature virus (IMV) activates a
signalling cascade involving Rac and protein kinase C [172].  The viral benefits of
signaling-independent entry are unknown.  On the other hand, emerging evidence
demonstrates that cell signalling during entry facilitates viral uptake and appropriate
intracellular targeting.
7.1. Regulated endocytic uptake
Many enveloped and non-enveloped viruses utilize an endocytic shuttle mechanism for
entry into host cells [reviewed in 173].  This ensures viral delivery to metabolically active
cells and helps to overcome a major cellular barrier, the cortical actin cytoskeleton [174].
However, actin does not play an obligatory role in receptor-mediated endocytosis but has
one or several important accessory roles [175; 176].  Enveloped RNA viruses, such as
the alpha viruses Sindbis and Semliki Forest virus and the orthomyxovirus influenza virus
19
enter independently of actin, presumably by constitutive endocytosis, i.e., through
receptors that are internalized from clathrin-coated pits in the absence of ligand [177].  In
contrast, most signalling receptors undergo ligand-induced endocytosis, as originally
discovered with the epidermal growth factor (EGF) receptor [178].  Emerging evidence,
however, suggests that constitutive clathrin-independent endocytosis is effectively used
by certain receptors, such as the Il-2 receptor [179].  Endocytosis assures that activated
receptors are removed from the surface and enables the cell to discriminate between old
and new signals.  In addition, endocytozed signalling receptors appear to have the ability
to emit signals that are distinct from those generated at the cell surface [for reviews, see
180; 181].  It remains to be shown, for example, if and how these signals are connected
to the large GTPase dynamin, which is implicated in multiple endocytic and intracellular
trafficking events.  Nonetheless, the endocytic pathway emerges as an important target
for viral manipulation during entry.
7.1.1. Adenoviruses
Human adenoviruses are small non-enveloped viruses with a capsid diameter of about
90 nm and are causative agents of widely different diseases [reviewed in 182].  They
deliver a linear double stranded DNA genome of about 36 kb into the nucleus of target
cells of a large range of tissues (see Fig. 2).  Human adenoviruses are classified into six
distinct subgroups A to F, with at least 51 serotypes.  For example, serotypes Ad-2 and
Ad-5 (subgroup C) are associated with upper airway infections, as is serotype Ad-3
(subgroup B).  Other serotypes (e.g., subgroup D) are linked to epidemic
keratoconjunctivitis, pneumonia (subgroup E), enteric infections (subgroup A) or
gastroenteritis (subgroup F).  The subgroup C adenoviruses are internalized by receptor-
mediated endocytosis [183], requiring Rab-5 [184] (Fig. 2).  Rab-5 is a regulator of
clathrin-coated vesicle formation, homotypic early endosome fusion and early endosome
trafficking on microtubules [reviewed in 185].  Interestingly, the guanine nucleotide
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dissociation inhibitor (GDI) of Rab-5 which enhances the extraction of the inactive Rab-5-
GDP from membranes and boosts endocytosis of fluid phase markers has been reported
to be activated by p38/MAPK [186].  Activated p38/MAPK is, however, not required for
adenovirus endocytosis per se or endosomal escape, as indicated by quantitative
electron microscopy and cell surface trypsinization assays [131].  This suggests that
Rab-5 activation is not a limiting factor for adenovirus endocytosis.  Viral endocytosis is,
however, coordinated by a v integrins [73], requires the large GTPase dynamin [187] and
depends on actin-modulating G-proteins [101; 188].  The precise role of actin in viral
endocytosis is yet unknown.  Actin could be involved in membrane invagination, coated
pit formation and sequestration, detachment of the newly formed vesicle, or vesicular
movement towards the cytosol.  Given that incoming adenovirus activates PI3K and
stimulates membrane trafficking, it is likely that adenovirus endocytosis is ligand-induced
and tightly controlled.  Endocytic control mechanisms might be also involved in releasing
viral particles from endosomes since protein kinase C inhibitors block viral escape and
restrict incoming viruses to peripheral endosomes [101].
Less is known about the endocytic uptake of other adenovirus serotypes than subgroup
C.  The subgroup B viruses Ad-3 and Ad-7 utilize a different receptor than CAR for entry
and are eventually targeted to late endosomes and lysosomes from where they appear to
deliver their genome to the nucleus [189; 190].  The lysosomal localization of subgroup B
viruses is reminiscent of an Ad-2 mutant, the temperature sensitive mutant 1 (ts1) [191].
At the non-permissive temperature, ts1 particles lack a functional protease and contain
non-processed precursor polypeptides [192].  Ts1 particles are 100 to 1000 times less
infectious than wild type Ad-2 but nonetheless enter cultured cells on a CAR and a v
integrin-dependent manner [193] and also trigger PI3K [165].  However, they seem to
enter cells without detectable activations of MAPK pathways [131] and end up in late
endosomes and lysosomes where they are degraded [193; 194].  These data suggest
that endocytic sorting of viral vesicles is regulated by cell signaling, and may hold key to
determining the early course of infections.
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7.1.2. Parvoviruses
Parvoviruses are very small DNA animal viruses with diameters of 18-26 nm.  Members
of the parvovirinae subfamily infect vertebrates and replicate in the nucleus of
proliferating cells, either autonomously or non-autonomously [reviewed in 195].  The
latter require coinfection with an unrelated virus (e.g., adenovirus or herpesvirus) and are
called dependoviruses or adeno-associated viruses (AAVs).  Although several clinical
disorders are linked to parvovirus infections, e.g. with the human blood progenitor cell-
tropic B19 isolate, little is known about the entry mechanism of human parvoviruses.
More entry information is available, however, about autonomous animal parvoviruses.
For example, canine parvovirus (CPV) and feline panleukopenia virus (FPV) are
pathogens of dogs and cats.  They are more than 99% identical in DNA sequence, but
differ in host range due to variations of surface exposed capsid loops [196].  An important
determinant of CPV and FPV entry appears to be the transferrin receptor [see Fig. 4B,
and 197], a constitutively internalized receptor without particular signalling properties.
Transferrin uptake occurs via clathrin-coated vesicles and incoming viruses colocalize
with internalized transferrin [198].  Accordingly, CPV uptake was inhibited by dominant-
negative dynamin K44A.  Lysosomotropic agents inhibited DNA amplification and viral
protein expression suggesting that at least one low pH compartment is required for
infection [199].  Neutralizing cytoplasmic anti-capsid antibodies inhibited infection as late
as 6 h post inoculation suggesting that escape of CPV from endosomes is slow [200].
The escape mechanism and further downstream events including nuclear import are
unknown, but it has been suggested that transport of cytoplasmically injected CPV
requires intact microtubules.  Less is known about other animal parvoviruses, but
electron microscopy suggested that mouse minute virus (MMV) enters cells via coated
pits [201].  By virtue of its capsid proteins VP1 and VP2 it somehow reaches the nuclear
membrane and releases its genome into the nucleoplasm [202].
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The dependo-virus adeno-associated virus (AAV) is a single-stranded DNA-containing
human parvovirus with low pathogenicity.  It has the potential to infect a large number of
cell types and is currently tested in clinical gene delivery trials.  Like Ad-2 and Ad-5, AAV-
2 seems to utilize a v integrins to coordinate endocytic uptake [see Fig. 4A, and 85], in a
dynamin-dependent manner [203; 204].  AAV-2 activates PI3K and Rac1, as wild type
and ts1 Ad-2 and slowly escapes from the endocytic compartment [168].  Inhibition of
PI3K with wortmannin or blocking Rac1 with dominant negative N17Rac1 inhibited AAV-2
mediated transgene expression.  It is clear that activations of PI3K and Rac1 are not
sufficient to specify the subcellular fate of endocytozed viral particles, since fluorescent
AAV-2 did not colocalize with fluorescent Ad-5 [204].  AAV-2 remained in the endocytic
pathway considerably longer than Ad-2.  Percoll density centrifugations of cell lysates
showed, for example, that incoming AAV-2 preferentially cofractionated with a lysosomal
marker in permissive human 293 cells, but cofractionated with transferrin when
internalized into the non-permissive mouse NIH-3T3 cells [205].  Furthermore, the proton
pump inhibitor bafilomycin A1 strongly delayed AAV-2 infection in human cells
suggesting the involvement of an acidic compartment [204-206].  In addition, the
depletion of microtubules with nocodazole also inhibited AAV-2 transgene expression
[168], consistent with the requirement of microtubules for endosomal trafficking to late
endosomes and lysosomes.  Interestingly, incoming AAV-2 is ubiquitinated and degraded
by the proteasome [206; 207].  Potentially, this pathway might serve as an uncoating or
an anti-viral defence mechanism.  How AAV-2 is sorted to late endosomes and
lysosomes and how it reaches the cytosol and imports its DNA genome remain
outstanding questions.
7.1.3. Other viruses
Papovaviruses are small icosahedral DNA viruses (50-60 nm capsid diameter), grouped
into the subfamilies papillomaviruses and polyomaviruses.  Simian virus 40 (SV40) is
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their best characterized member in terms of entry and signaling.  Unlike adenoviruses
and parvoviruses, SV40 enters cells by caveolar endocytosis, as indicated by
morphological analyses and expressions of dominant negative caveolin [208-211].
Caveolin is a major component of the detergent-insoluble, cholesterol-rich caveolar
membranes [212].  Binding of SV40 to target cells occurs via major histocompatibility
class 1 molecule.  SV40 entry into growth-arrested cells is associated with an immediate
transcriptional upregulation of c-myc and c-jun, independent of protein synthesis and viral
transcription [144].  Interestingly, these activations did not appear to affect Raf and ERKs
but were sensitive to inhibitors of tyrosine phosphorylation and protein kinase C.
Blocking tyrosine phosphorylation inhibited SV40 entry but apparently had no effect on
viral partioning into detergent insoluble membrane fractions, suggesting that tyrosine
phosphorylation may originate in caveolae [213].  It will be important to sort out how
these observations relate to the emerging notion that caveolin-containing microdomains
are vital organizers of cell signalling [for a review, see 214].  Further along the entry
pathway, SV40 particles are shuffled to perinuclear smooth endoplasmic reticulum (sER)
[215], and somehow deliver their DNA genome into the nucleus [reviewed in 15; 216].  It
can be expected that these sorting events are coordinated by cell signaling, although the
reasons for SV40 targeting to the sER are currently not understood.  It is worth noting
that a virus unrelated to SV40, the human parechovirus (HPEV) of the picornavirus family
of RNA viruses replicating in the cytoplasm has been found in the ER as well [217].
HPEV is thought to enter cells by clathrin-mediated endocytosis, presumably in an a v
integrin-dependent manner, passes through EEA-1 positive early endosomes and is
routed to late endosomes and lysosomes.  This illustrates once again that navigating
through intracellular traffic is a skill of crucial importance for many different viruses.
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7.2. Regulation of cytoplasmic motility
Initially, video-enhanced microscopy and digital image processing were used to observe
enveloped viruses budding from the cell surface in living cells [218].  The first fluorescent
viruses were the nonenveloped viruses adenovirus and reovirus, which allowed the
visualization of overall viral entry features, such as capping of particles at the cell surface
[189; 219; 220], and cytosolic virus motility by time lapse fluorescence microscopy [221].
Major progress in fluorescent imaging technologies during the last decade has allowed to
apply more accurate and less invasive procedures [222-224], and analyses of numerous
viruses either labeled with small fluorescent molecules or with green fluorescent protein
(GFP) are under way in many different laboratories [e.g., 132; 168; 204; 211; 225; 226-
231].
From measurements of the fluorescence recovery after photobleaching of microinjected
dextrans and ficoll beads it can be expected that the diffusional properties of viruses are
considerably smaller in the cytoplasm than in aqueous media [232; 233].  If these
particles do not bind to slowly diffusing cytoplasmic structures, this means that
cytoplasmic crowding with large obstacles, such as filaments and organelles might
restrict passive diffusion of cytosolic virus particles.  Organelle motion is often dependent
on molecular motors that convert the energy of ATP into mechanical work and move
along cytoplasmic filaments.  This is reflected by a large body of live cell experimentation
in continuous mode indicating that organelles are moving in a stop and go fashion with
periods of motility and inactivity [for a review, see 234].  Since active motor complexes
seem to be relatively rare and may be activated or recruited to a large variety of cargo by
positional information, it is expected that movement of cargo, including viruses is tightly
controlled.  Indeed, intracellular motility of virus particles turns out to be an important
determinant of infections [for recent reviews, see 235; 236; 237].
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7.2.1. Adenovirus
Ad-2 and Ad-5 escape from the endosomal pathway long before virus-bearing
endosomes have arrived in a perinuclear location (see Fig. 2).  Texas-Red labeled
viruses and quantitative microscopy in both static and time lapse modes combined with
electron microscopy revealed that cytosolic Ad-2 uses bidirectional microtubule-
dependent cytoplasmic transport to reach the nuclear membrane [227; 238; 239].  The
population speed of virus targeting to the nucleus was in the order of µm min-1, but peak
speeds reached 2.6 µm sec-1.  Virus transport to the minus ends of microtubules near the
nucleus is mediated by the cytoplasmic dynein/dynactin motor complex which operates at
velocities of µm sec-1.  A first hint on possible regulatory mechanisms of viral motility
came from the observation that microinjected native Ad-2 was essentially immotile but
could be stimulated to move when the cell was challenged by an authentic Ad-2 infection
[131].  Further experiments revealed that incoming Ad-2 induced two discrete signalling
pathways from the cell surface that modulate viral motility (see Fig. 3).  The first pathway
activated protein kinase A (PKA) and required upstream a v integrins.  The second
pathway was independent of integrins and activated the p38/MAPK cascade, a central
component of innate immunity and host cell defence.  Knocking out the p38-activating
MAPK kinase MKK6 by overexpression of dominant negative MKK6 strongly inhibited
nuclear targeting of Ad-2 and resulted in viral accumulation in the periphery.  p38
stimulation by Ad-2 appeared to be required to suppress plus end-directed transport
towards the periphery, and the p38 target MAPKAP kinase 2 (MK-2) to boost the
frequencies of minus end-directed transport steps.  These results demonstrate that
incoming Ad-2 not only modulates the transcriptional environment of an infected nucleus,
but also tips the activities of cytoplasmic transport machineries to favor the infection.  In
analogy with lipid droplet movements in Drosophila embryos [240; 241], one might
speculate that Ad-2 utilizes bidirectional microtubule-mediated transport to stay on track
and to possibly overcome a limiting processivity of motor proteins.  On the other hand,
plus end-directed transport along microtubules might be important for the virus to reach
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particular subcellular locations, such as the plasma membrane during viral egress.  A
switching mechanism of transport could be directly or indirectly regulated by PKA, p38
and MK-2, and perhaps additional factors such as the viral structure.  That minus end
targeting is regulated by a v integrin-dependent and independent pathways correlates with
the notion that Ad-2 uses multiple secondary receptors for entry [78].  It will be interesting
to see how other viruses that encode their own kinases manipulate the cellular signal
transduction machinery for entry.
7.2.2. Other viruses
Vaccinia virus of the poxvirus family replicates its DNA genome in the cytoplasm, and
takes advantage of cytoplasmic trafficking to facilitate spread and cell exit.  Microtubules
and the dynein/dynactin motor complex have a role in the formation of intracellular
mature virus (IMV) and also intracellular enveloped virus (IEV), in part virally encoded
microtubule-associated proteins binding to viral cores [242].  Recent studies show that
intracellular vaccinia virus utilizes microtubule-dependent motility to reach to the cell
surface [243-245], and actin comet tail formation was observed on newly synthesized
vaccinia virus [246].    While actin tail formation is not necessary for cytoplasmic motility it
clearly occurs when extracellular virus attaches to the plasma membrane.  This is
critically dependent on two critical tyrosine residues (112 and 132) of the viral protein
A36R [247; 248].  Although the microtubule-dependent motors and the viral binding
partners driving virus to the periphery are currently unknown, these results show that
vaccinia virus alters the function of microtubules and utilizes actin polymerization to
support spreading from cell to cell.  Further examples of viral particles utilizing
microtubules for trafficking include the enveloped DNA virus african swine fever virus
[249], HSV-1 [250], the retrovirus foamy virus [251] and bovine papilloma virus [252]. .  In
addition, a number of viruses encode proteins that either stabilize [253] or reorganize
microtubules [254; 255], or bind to microtubule-associated proteins [256-259], actin [260]
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or intermediate filaments [261] and alter transport functions [262; 263].  Clearly, viruses
exploit a wealth of opportunities to interfere with cell trafficking and morphology.  We are
just beginning to understand the underlying mechanisms.
8. Perspectives
Viruses are versatile, ubiquitous carriers of genetic material.  Their mission is to replicate
and produce progeny.  Viral entry is a most critical process setting off the infection.  It is
highly regulated and often coordinated by signalling of cellular and viral factors.
Prevailing evidence indicates that signals generated by virus-receptor interactions at the
cell surface affect both viral and cellular gene expressions.  Emerging evidence shows
that signals from incoming virus particles bear on the efficiency of early entry steps,
including virus uptake, escape to cytosol, cytoplasmic transport and nuclear import.  A
major challenge will be to integrate cell signalling into transport and anchoring functions
of the cytoskeleton and determine how cargo trafficking feeds back into amplification or
extinction of signals.  Viruses may well play a role model in such investigations.  Further
understanding of virus-cell signalling will broaden our knowledge of virally caused
disease and eventually lead to new anti-viral agents.  A more detailed understanding of
entry will enhance the development of retargeted viral vectors for selective therapeutic
applications.  Viruses with a flexible lipid envelope or with a modular lipid-free structure
are initially preferred targets, but recent developments of soluble linker proteins may also
allow efficient retargeting of rigid viral capsids.  In any case, retargeted viruses may
ideally activate cell signalling at the time of vector binding to the target cell, similar to
native infections.  This will fine tune both viral entry and transcriptional control of the
transgene to yield optimal and sustained gene expression.
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10. Figure legends
Fig. 1: Three modes of viral activations of host cells
The most prevailing activation mode occurs by viral gene expressions (panel A).
Incoming viruses deliver their genes to subcellular replication sites (steps 1 and 2) and
from there drive the transcription of viral genes encoding intracellular (steps 3a and 4a)
and extracellular signalling factors (steps 3b and 4b).  Panel B: The second mode of
signalling is a delivery of proteins or nongenomic mRNAs by incoming viruses (step 1).
These molecules can interfere with cell signalling (steps 2 and 3).  Panel C: During entry,
many incoming viruses recruit a primary receptor (step 1) and/or a secondary receptor
with signalling functions (step 2) and thus lead to cell activation (step 3).
Fig. 2: Generic view of subgroup C adenovirus entry
Ad-2 or Ad-5 bind to the coxsackievirus-adenovirus receptor (CAR) and the secondary
receptor a v integrin and enter cells by receptor-mediated endocytosis via coated pits and
coated vesicles.  Early entry steps require PI3K, Rac1 and Cdc42 and also dynamin.
Virus then escapes from endosomes by an unknown mechanism somehow assisted by
low pH.  Cytosolic virus particles are then transported by the dynein/dynactin motor
complex along microtubules in minus end direction towards the nucleus.  Nuclear pore
complex-docked virus particles are dismantled and the DNA genome released into the
nucleus.
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Fig. 3: Cell signalling by incoming subgroup C adenoviruses
Ad-2 and Ad-5 activate a v integrin heterodimerized to b 5.  This stimulates PI3K, the
adaptor protein p130/CAS, Rac1 and Cdc42 and promotes actin dynamics and endocytic
trafficking of virus.  In addition, incoming Ad-2 sheds its fiber proteins at the cell surface.
This reaction depends on CAR and a v integrins.  Protein kinase C (PKC) is involved in
endosome transport and viral escape.  Whether the primary adenovirus receptor CAR
alone has signalling function is unknown.  A second branch of integrin signalling occurs
through Ras/Raf/ERK1,2 and leads to an inflammatory and migratory response.  A
further player downstream of integrins is protein kinase A (PKA).  It is activated by
incoming Ad-2 and stimulates viral transport along microtubules in minus end direction.
An integrin-independent pathway signals through MKK6/p38/MK2/Hsp27 and stimulates
viral transport to the nucleus.  p38 activation by incoming virus also activates
transcription of the cytokines IL-6 and TNF- a .
Fig. 4: Trafficking of incoming parvoviruses
Panel A: The dependovirus AAV-2 binds to cell surface heparan sulfate proteoglycans
(HSPG), a vb 5 integrins and fibroblast growth factor receptor (FGFR) 1 and is internalized
by receptor-mediated endocytosis in a dynamin and Rac1-dependent manner.  PI3K
appears to regulate endosome trafficking.  AAV-2 is transported from early endosomes to
late endosomes and lysosomes depending on microtubules.  Virus escapes and releases
its single stranded DNA genome into the nucleus.  Panel B: The helper-independent
canine parvovirus (CPV) binds to the transferrin receptor (TfnR) and is internalized
presumably by clathrin-dependent endocytosis.  In early endosomes, it is sorted to
recycling endosomes from where it may be released into the cytosol and reach the
nucleus by microtubule-dependent trafficking.  Like in the case of AAV-2, it is unknown
how its single stranded DNA genome is imported into the nucleus.
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